Protagonist Therapeutics PTGX
NASDAQ PTGX
$134.86 -1.40 (-1.03%)
At close: Nov 11, 2026 · 4:00 PM EST

Protagonist Therapeutics (PTGX) Amortization of Deferred Charges (2016 - 2020)

Updated

Analysis

Protagonist Therapeutics (PTGX) Amortization of Deferred Charges (2016 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Protagonist Therapeutics 8.89 Bn 6.19 Bn 273.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 15,000.00
Jun 30, 2020 -23,000.00
Mar 31, 2020 45,000.00
Dec 31, 2018 -98,000.00
Sep 30, 2018 194,000.00
Jun 30, 2018 -10,000.00
Mar 31, 2018 120,000.00
Dec 31, 2017 190,000.00
Sep 30, 2017 225,000.00
Jun 30, 2017 150,000.00
Mar 31, 2017 122,000.00
Dec 31, 2016 35,000.00
API Access

Protagonist Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=PTGX&period=max&api_key=YOUR_API_KEY